# Ra Pharmaceuticals, Inc. — Form D

Ra Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-24. The offering totals $27.6M, of which $10.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-02-24
- Form: D
- Accession: 0001481512-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $27.6M
- Amount sold: $10.3M
- Remaining: $17.3M
- Investors: 5
- Date of first sale: 2010-02-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-139021

## Issuer

- Name: Ra Pharmaceuticals, Inc.
- CIK: 0001481512
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: (617) 401-4060

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| James W Broderick | Director | Malvern, PA |
| Edward W Mathers | Director | Boston, MA |
| Lauren W Silverman | Director | Boston, MA |
| Theodore A Laufik | Executive Officer | San Diego, CA |
| Peter A Bisgaard | Director | Redwood City, CA |
| Rajeev A Shah | Director | Cambridge, MA |
| Douglas A Treco | Director | Cambridge, MA |
| Douglas A Treco | Executive Officer | Cambridge, MA |
| Edward A Mathers | Director | Cambridge, MA |
| Jason A Lettman | Director | Cambridge, MA |
| Kerry A Black | Executive Officer | Cambridge, MA |
| Markus A Goebel | Director | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-07-23](https://search.stillhousedata.com/formd/0001481512-15-000002) | D | $58.5M | $29.2M |

## More

- [CIK 1481512 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1481512&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001481512-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.